Harvard Bioscience makes laboratory instruments and software used in life science research and preclinical drug testing. HBIO reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 12 | Benchmark | Maintained | Buy |
Seasonality
How HBIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in HBIO in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HBIO is in one of them and how their past HBIO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered HBIO in an article yet. Here's the latest on the wider market.
About Harvard Bioscience
Harvard Bioscience makes laboratory instruments, consumables, software and services used in life science research, drug discovery and preclinical testing. Its products include electroporation systems, syringe pumps, spectrophotometers, electrophysiology equipment and telemetry systems that collect data from research animals. Customers include pharmaceutical and biotechnology companies, contract research organizations, universities and government laboratories. The company is based in Holliston, Massachusetts, and sells in the United States, Europe and China.
- Headquarters
- Holliston, MA
- Founded
- 1901
- Website
- harvardbioscience.com ↗